Literature DB >> 34181151

PET/CT F18-FDG with soft tissue plasmacytomas in multiple myeloma.

Alejandro Martí1, Sarai Morón2, Sandra Chinchilla3, Eliana González4.   

Abstract

Multiple myeloma is characterized by malignant proliferation of clonal plasma cells. Usually, appears as a generalized disease but it can present as solitary bone plasmacytoma or a solitary soft tissue mass or extramedullary plasmacytoma. In the case of extramedullary involvement, it could present as soft tissue plasmacytomas and the prognosis is poor. The 18F-FDG PET/CT could be a valuable tool for characterization of the medullary and extramedullary involvement. We present a case of F18-FDG PET/CT with extramedullary involvement with soft tissue plasmacytomas in the setting of MM.

Entities:  

Keywords:  F18-FDG PET/CT; Multiple myeloma; Plasmacytoma; Soft tissue

Year:  2021        PMID： 34181151     DOI： 10.1186/s41824-021-00100-7

Source DB:  PubMed          Journal:  Eur J Hybrid Imaging        ISSN： 2510-3636


  12 in total

1.  Primary cutaneous plasmacytoma presenting with multiple subcutaneous nodules by F-18 FDG imaging.

Authors:  Ilknur Ak; Zafer Gülbas
Journal:  Clin Nucl Med       Date:  2007-01       Impact factor: 7.794

Review 2.  Multiple myeloma.

Authors:  Antonio Palumbo; Kenneth Anderson
Journal:  N Engl J Med       Date:  2011-03-17       Impact factor: 91.245

3.  Extramedullary involvement in multiple myeloma.

Authors:  Joan Bladé; Carlos Fernández de Larrea; Laura Rosiñol
Journal:  Haematologica       Date:  2012-11       Impact factor: 9.941

4.  FDG PET/CT depicts cutaneous plasmocytoma.

Authors:  Constantin Lapa; Stefan Knop; Katharina Lückerath
Journal:  Clin Nucl Med       Date:  2014-10       Impact factor: 7.794

Review 5.  Extramedullary multiple myeloma.

Authors:  Manisha Bhutani; David M Foureau; Shebli Atrash; Peter M Voorhees; Saad Z Usmani
Journal:  Leukemia       Date:  2019-11-27       Impact factor: 11.528

Review 6.  Role of 18F-FDG PET/CT in the diagnosis and management of multiple myeloma and other plasma cell disorders: a consensus statement by the International Myeloma Working Group.

Authors:  Michele Cavo; Evangelos Terpos; Cristina Nanni; Philippe Moreau; Suzanne Lentzsch; Sonja Zweegman; Jens Hillengass; Monika Engelhardt; Saad Z Usmani; David H Vesole; Jesus San-Miguel; Shaji K Kumar; Paul G Richardson; Joseph R Mikhael; Fernando Leal da Costa; Meletios-Athanassios Dimopoulos; Chiara Zingaretti; Niels Abildgaard; Hartmut Goldschmidt; Robert Z Orlowski; Wee Joo Chng; Hermann Einsele; Sagar Lonial; Bart Barlogie; Kenneth C Anderson; S Vincent Rajkumar; Brian G M Durie; Elena Zamagni
Journal:  Lancet Oncol       Date:  2017-04       Impact factor: 41.316

Review 7.  Soft-tissue plasmacytomas in multiple myeloma: incidence, mechanisms of extramedullary spread, and treatment approach.

Authors:  Joan Bladé; Carlos Fernández de Larrea; Laura Rosiñol; María Teresa Cibeira; Raquel Jiménez; Ray Powles
Journal:  J Clin Oncol       Date:  2011-09-06       Impact factor: 44.544

Review 8.  Fluorodeoxyglucose-PET/Computed Tomography as a Predictor of Prognosis in Multiple Myeloma.

Authors:  Cristina Nanni; Elena Zamagni
Journal:  PET Clin       Date:  2019-04-19

9.  MR imaging and PET/CT in diagnosis and management of multiple myeloma.

Authors:  Regan Ferraro; Ankit Agarwal; Erica L Martin-Macintosh; Patrick J Peller; Rathan M Subramaniam
Journal:  Radiographics       Date:  2015 Mar-Apr       Impact factor: 5.333

10.  Soft-tissue extramedullary multiple myeloma prognosis is significantly worse in comparison to bone-related extramedullary relapse.

Authors:  Ludek Pour; Sabina Sevcikova; Henrieta Greslikova; Renata Kupska; Petra Majkova; Lenka Zahradova; Viera Sandecka; Zdenek Adam; Marta Krejci; Petr Kuglik; Roman Hajek
Journal:  Haematologica       Date:  2013-09-13       Impact factor: 9.941
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.